NBTX vs CCS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NBTX · Nanobiotix$30.63 ▲ 2.03%
CCS · Century Communities$55.21 ▼ 3.21%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NBTX +38.2%
- CCS -4.9%
Head to head
| Metric | NBTX | CCS |
|---|---|---|
| Price | $30.63 | $55.21 |
| Change today | ▲ 2.03% | ▼ 3.21% |
| Market cap | $1.56B | $1.56B |
| Return, 3 months | -15.3% | -19.5% |
| Return, year to date | +32.5% | -5.5% |
| Return, 1 year | +54.2% | -6.1% |
| P/E (TTM) | – | 14.7 |
| P/B | -41.7 | 0.6 |
| P/E percentile vs own 5y | 11th | 94th |
| Dividend yield | – | 2.26% |
| Revenue growth (YoY, latest qtr) | +355.3% | -11.8% |
| Net profit growth (YoY) | +64.8% | -66.3% |
| Gross margin | – | 16.8% |
| Operating margin | -353.6% | 3.8% |
| Net margin | -632.5% | 2.9% |
| Return on equity | – | 4.2% |
| Analyst target vs. price | +108.9% | – |
| Analyst buy share | 100% | – |
| RSI (14) | 54 | 46 |
| 30-day volatility | 98.0% | 49.9% |
| Max drawdown, 1 year | -61.7% | -35.0% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CCS is the largest of the group by market value.
- NBTX has returned the most over the past year.
- NBTX is growing revenue fastest.
- CCS keeps the most profit per dollar of sales.
- CCS has been the calmest stock over the last 30 days.